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Abstract
Background: Physical activity prevents or delays progression of impaired glucose tolerance in high-risk individuals.
Physical activity promotion should serve as a basis in diabetes care. It is necessary to develop and evaluate
health-promoting methods that are feasible as well as cost-effective within diabetes care. The aim of Sophia Step
Study is to evaluate the impact of a multi-component and a single component physical activity intervention aiming
at improving HbA1c (primary outcome) and other metabolic and cardiovascular risk factors, physical activity levels
and overall health in patients with pre- and type 2 diabetes.
Methods/design: Sophia Step Study is a randomized controlled trial and participants are randomly assigned to
either a multi-component intervention group (A), a pedometer group (B) or a control group (C). In total, 310
patients will be included and followed for 24 months. Group A participants are offered pedometers and a website
to register steps, physical activity on prescription with yearly follow-ups, motivational interviewing (10 occasions)
and group consultations (including walks, 12 occasions). Group B participants are offered pedometers and a website
to register steps. Group C are offered usual care. The theoretical framework underpinning the interventions is the
Health Belief Model, the Stages of Change Model, and the Social Cognitive Theory. Both the multi-component
intervention (group A) and the pedometer intervention (group B) are using several techniques for behavior change
such as self-monitoring, goal setting, feedback and relapse prevention.
Measurements are made at week 0, 8, 12, 16, month 6, 9, 12, 18 and 24, including metabolic and cardiovascular
biomarkers (HbA1c as primary health outcome), accelerometry and daily steps. Furthermore, questionnaires were used
to evaluate dietary intake, physical activity, perceived ability to perform physical activity, perceived support for being
active, quality of life, anxiety, depression, well-being, perceived treatment, perceived stress and diabetes self- efficacy.
Discussion: This study will show if a multi-component intervention using pedometers with group- and individual
consultations is more effective than a single- component intervention using pedometers alone, in increasing physical
activity and improving HbA1c, other metabolic and cardiovascular risk factors, physical activity levels and overall health
in patients with pre- and type 2 diabetes.
Trial registration: ClinicalTrials.gov Identifier: NCT02374788. Registered 28 January 2015.
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Background
Having type 2 diabetes, but also pre-diabetes increases
the risk of cardiovascular disease (CVD) and premature
death [1]. Physical activity on a regular basis enhances
metabolic control [2, 3], improves blood lipid profile,
blood pressure and quality of life [2, 4]. Several studies
have shown preventive effects of physical activity in indi-
viduals with impaired glucose tolerance [5–9] and phys-
ical activity in persons with type 2 diabetes clearly
lowers the risk of cardiovascular disease and premature
death [10, 11]
The recently updated Swedish recommendations for
physical activity for persons with type 2 diabetes are in
line with the US PA Guidelines recommendation of
2008 [12, 13]. The recommendations are “To undertake
at least 150 min per week of moderate to vigorous inten-
sity aerobic physical activity spread out during at least 3
days during the week with no more than two consecu-
tive days between the bouts and moderate to vigorous
resistance training at least 2-3 days per week [2, 12].
There is a dose–response relationship between aerobic
physical activity and health gains, and activity duration
beyond 150 min per week is associated with an even
greater decline in HbA1c [14] as well as a reduced risk of
cardiovascular disease and all-cause mortality in patients
with diabetes [10]. An increased body of evidence is
pointing at the importance of resistance training or com-
bined training for blood glucose control [2, 3, 15] and a
high relative muscle mass for better insulin sensitivity
[16]. It is also evident that reducing sedentary time and
breaking up sitting time may give additional health ben-
efits over the recommended activities and might be of
importance especially for the most inactive and unfit in-
dividuals [2, 17, 18]. The most important component to
maintain these beneficial effects seems to be continuous
repetition and it is therefore crucial that physical activity
is perceived as enjoyable and that it is incorporated in
daily routines [2]. In the Swedish population, 52 % of
adults are regarded as being sufficiently active [19] and
self-reported data from the Swedish National Diabetes
Register showed that in the population with diabetes 55 %
reached 3 × 30 min per week [11]. It is considered crucial
to find and evaluate strategies to increase the adoption
and maintenance of regular physical activity in the popula-
tion with pre-and type 2 diabetes [2, 11].
Advising physical activity is both cost-effective and
feasible in primary care [20, 21] and promotion of
physical activity should serve as a basis in diabetes care
[1, 22]. The Board of Health and Welfare (Socialstyrel-
sen) in Sweden gives high priority to physical activity in
diabetes care and since 1999 strongly recommends pri-
mary care to provide advice and support for individuals
with diabetes as well as for individuals with increased
risk for developing diabetes [23, 24]. Given the low
number of people with diabetes being sufficiently active,
the promotion of physical activity in the Swedish dia-
betes care is not satisfactorily effective today and needs
to be improved [25].
In the literature, a number of methods reinforcing
physical activity promotion in primary care have been
evaluated and shown to be effective. The World Health
Organization put emphasis on primary care to encour-
age and support people to take better care of their own
health and to use evaluated tools and technology for this
purpose [26]. Pedometers have been helpful in increas-
ing physical activity levels and in improving metabolic
parameters in patients with diabetes in several previous
studies [27–29]. Pedometers have also been efficient in
increasing the number of steps with a subsequent im-
provement in blood pressure even in already healthy in-
dividuals [30]. An advantage with pedometers is their
efficiency in increasing the motivation to be more active
and less sedentary on a daily basis, which is especially
important for metabolic control and in lowering blood
pressure. Well-planned group counseling sessions led by
health professionals have also been shown to be effective
in reducing diabetes risk in several previous interven-
tions [28, 31–33]. The group setting offers social support
and a pronounced opportunity for participants to share
experiences, encouragement and to strengthen change.
Group education is emphasized in the Swedish diabetes
care [23, 24] but is today used by only 24 % of primary
care units [25].
Recent reviews on physical activity interventions in
primary care demonstrate that exercise prescription is a
successful method to increase physical activity up to 12
months [21, 34]. In the Swedish primary care, a treatment
method named FaR® (abbreviation for Physical Activity on
Prescription) is recommended for use in a number of
diseases including type 2 diabetes [35]. The focus is on
person-centered counseling and the current diagnosis,
health status, history of physical activity, risks and prefer-
ences of the individual serves as a basis for the counseling.
FaR is based on Social Cognitive Theory and the Stages of
Change Model. In an evaluation 2010 87 % of the Swedish
health care centers had implemented FaR [36].
Motivational Interviewing is a counseling method using
a person-centered approach [37]. There is some inconsist-
ency in the evidence for motivational interviewing both in
diabetes care and in increasing physical activity in the pri-
mary care setting: unfortunately many studies fail to pick
up treatment fidelity, the qualification of the professionals
delivering the treatment, mode of delivery and interven-
tion intensity [38, 39]. Alongside with other intervention
components, such as self-monitoring, physical activity on
prescription and offering more than two motivational
interviewing sessions the efficacy may be improved [39]. In
the promotion of physical activity flexibility using various
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approaches is recommended [40–42] as well as to tailor
the intervention to the individual [43].
There is still a gap in the evidence on which methods,
what intervention components and what support inten-
sity would be most effective in increasing long-term
physical activity in in the primary care setting for per-
sons with pre- and type 2 diabetes [21, 43, 44]. More
evidence is also needed on maintenance strategies for
long-term effectiveness [33, 44].
Based on these identified gaps in knowledge, Sophia Step
Study has been developed as an evidence-based structured,
two-year health promotion program at two intensity levels
of support focusing on physical activity and aimed for the
primary care setting. The study aims to evaluate and ex-
plore the impact of two levels of intervention intensities of
physical activity support on health parameters.
The aim of this paper is to describe the design and
recruitment procedure, methods, and the theoretical
framework for the physical activity promotion program
Sophia Step Study.
Methods/design
Main objective
The main objective of Sophia Step Study is to evaluate the
impact of a multi- component and a single-component pri-
mary care physical activity intervention aiming at improv-
ing HbA1c (primary outcome) and other metabolic and
cardiovascular risk factors, physical activity levels and over-
all health in patients with pre-diabetes and type 2 diabetes.
Hypothesis
The hypothesis is that both levels of intervention have
effect on the primary outcome HbA1c, with the multi-
component intervention having superior and longer last-
ing effects.
Study design and recruitment
The Sophia Step Study is a two-year randomized controlled
trial (RCT) with three parallel groups. The CONSORT
statement is followed [45]. The study takes place at the
primary health care centers at Sophiahemmet, Stockholm,
Sweden.
All patients at the health care centers diagnosed with
pre-diabetes and type 2 diabetes and fulfilling the inclusion
criteria are informed of the study and asked whether they
are interested in participating (Fig. 1). Patients showing
interest receive a letter with further information and are
subsequently interviewed over telephone by the diabetes
specialist nurse and asked a set of inclusion/exclusion
questions. If they fulfil the inclusion criteria they are
booked for a baseline control.
Inclusion criteria
Age 40-80 years and ability to communicate in Swedish.
Either Pre-diabetes (HbA1c > 39- < 47 mmol/mol and/or
fasting glucose >5.6 mmol/l) or diagnosed with type 2
diabetes with a duration of ≥1 year.
Exclusion criteria
Myocardial infarction in the past 6 months, serum creatinine
>140 mmol/l, diabetic foot ulcer or risk of ulcer (severe
peripheral neuropathy), on insulin since the last 6 months,
additional disease prohibiting physical activity, repeated
hypoglycemia or severe hypoglycemia in the past 12 months,
being very physically active according to the Stanford Brief
Activity Survey [46] or having no access to internet.
Fig. 1 Recruitment procedure and randomization of Sophia Step Study subjects
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Procedure and timeline
The baseline measurements start with an examination by
the patient’s general practitioner for exclusion purposes. A
notification is made on subjects not fulfilling the criteria
at this stage. The study-specific measurements are made
by the diabetes specialist nurse or a trained assistant,
followed by randomization to three groups using closed
envelopes while stratified by gender. The participants are
randomly assigned to either the multi-component inter-
vention group (A), the single component group (B) or a
control group (C). A total of 310 patients with pre- dia-
betes or type 2 diabetes will be included gradually, with
the aim of 100 participants included in group A and B,
and 110 in the control group C by the end of 2017. After
randomization, participants are given a schedule for meas-
urement time points and group A participants receive a
schedule for group sessions and individual consultations.
The intervention lasts for 24 months, with more intensive
support from the health care professionals within the first
24 weeks, and less support in the second year (Fig. 2).
Sophia Step Study started with a pilot group in March
2013, entailing 8 participants in group A and 6 in group
C. The pilot revealed compliance to the protocol and
ability to recruit and the first participants were recruited
in November 2013. The plan is to have 310 participants
completed the intervention in 2020.
Intervention
Pedometer
In week 1, participants in the intensive intervention
group (A) and the pedometer group (B) arrive for their
second visit at the health care center. They are offered a
pedometer (YAMAX; model Yamax Digiwalker SW 200:
Yamax Corporation, Tokyo, Japan), instructions for how
to use the pedometer, how to record their daily steps and
to set a daily step goal on a website (www.steg.se, Select
Wellness AB, Stockholm, Sweden). The participants regis-
ter steps daily in a diary, and are recommended to enter
them onto the website weekly. Non-ambulant activities
such as biking and swimming are translated into steps by
a simple calculation (each 30 min of activity, regardless of
intensity, gives 3500 steps). On the website a “healthy
goal” of minimum 7000 step per day is depicted as a refer-
ence [47]. The participants are asked to decide on individ-
ual goals after the first week of wearing the pedometer. If
a pedometer stops working or gets lost the participants
are encouraged to pick up a new pedometer at the health
care center or a new pedometer is sent by post.
Group counseling
Group A participants are offered 12 group meetings
(Fig. 2) over two years’ time, with the majority of meet-
ings being held in the first six months. The group meet-
ings include a 30 min walk and 60 min group consulting
and are steered by a health professional trained in phys-
ical activity promotion and familiar with models and
techniques for behavior change. A workbook developed
for the project, based on the Health Belief Model, the
Stages of Change Model and Social Cognitive Theory is
used. The content of the group counseling program and
the behavior change techniques used is shown in Fig. 3.
The order of the content may shift depending on
holidays, season or other concerns that arise.
Person-centered individual counseling
Group A participants are offered individual consultations
with their diabetes specialist nurse at 9 occasions. The
nurses are trained in MI and are using an MI-spirit in their
consultations. The consultation takes place concurrently
Fig. 2 Time frame for Sophia Step Study. Time points for intervention components (grey) and data collection (black) for all groups. *Including
blood samples, anthropometric and physical activity measurements and questionnaires. More details are depicted in Table 1
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with the study measurements and the health outcomes
from the measurements and the number of steps taken
recently serves as a basis for these talks. Moreover, the
nurse is, during one of the first MI-talks prescribing phys-
ical activity according to the method FaR [35]. The nurse
also informs participants about the opportunities that
follow a prescription, such as subsidies to gyms and sport
clubs and trained staff at certain sport clubs. The
prescription is followed up yearly. All in all, the meetings
take 45-60 min each.
Usual care
The control group (C) receives diabetes care as usual,
except for the extra measurements included in the study.
Usual care consists of seeing a diabetes specialist nurse
and a general practitioner at least once a year and
receiving lifestyle advice, including advice on physical
activity. Depending on the metabolic status of the
patient there might be consultations with both the nurse
and/or the general practitioner more often. The number
of consultations made will be recorded for each
Fig. 3 Group counseling program for group A with the content and the behavior change techniques
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participant. A physical activity prescription might also
be issued as a part of usual care, but not in a systematic
way.
Theoretical framework
It is widely recommended that program design should
be based on a theory and the behavior change tech-
niques used should be depicted to improve evidence
synthesis [21, 43, 48]. The theoretical framework under-
pinning the two interventions in Sophia Step Study is
the Health Belief Model, the Stages of Change Model
and the Social Cognitive Theory [49]. Both the multi-
component intervention (group A) and the pedometer
intervention (group B) are using several behavior change
techniques based on the CALO-RE taxonomy [48].
Based on these theories various intervention compo-
nents were chosen to offer flexibility; to adjust to
individual differences and preferences and to strengthen
change. A conceptual framework visualizing the inter-
vention program is depicted in Fig. 4.
Outcome measures
Measurements are made on all participants at week 0, 8,
12, 16, 24, month 9, 12, 18 and 24. The primary outcome
variable is HbA1c. Health outcomes and measurement time
points are summarized in Table 1. The measurements are
planned to be performed within ± 2 weeks and notes are
made if they are made sooner or later than this.
Biomarkers
Measurements include fasting blood samples on HbA1c
(mmol/mol), plasma glucose (mmol/l), triglycerides
(mmol/l), LDL (mmol/l), HDL (mmol/), total Choles-
terol (mmol/l), free fatty acids (mmol/l), Insulin (mU/l),
IGF BP1 (μ/l), Apolipoprotein-A1 (g/l), Apolipoprotein B
(g/l) and C-peptid (nmol/l). HbA1c, haemoglobin A1c (ref
< 5.2 %) is determined with immunologic MonoS method,
Unimate (Roche Diagnostics, Basel, Schweiz). To convert
HbA1c MonoS into HbA1c (DCCT) NGSP (National
Glycoprotein Standardization Programme) the formula,
NGSP = 0.92*MonoS + 1,33 is used. Plasma glucose are
determinedwith a glucose oxidase method, total Cholesterol
and triglycerides are determined by using enzymatic
method, LDL and HDL are determined by using a
homogeneous method, Apolipoprotein-A1 and Apoli-
poprotein B are determined by using turbimetric
method and C-peptid are determined by using
immunometric method using two monoclonal anti-
bodies and detection with electrochemiluminiscense
using a Modular E system (Beckman Coulter, Inc.). Serum
insulin concentrations are determined with RIA-kits pur-
chased from Pharmacia & Upjohn, Stockholm. IGFBP-1
concentrations in serum are determined by RIA according
Fig. 4 Conceptual framework of Sophia Step Study. The conceptual framework depicts the underlying theories, the intervention components
with the behavior change techniques used and the expected outcomes for the two intervention groups
Rossen et al. BMC Public Health  (2015) 15:647 Page 6 of 11
Table 1 Outcome parameters and time points for measurements for all groups in Sophia Step Study
Variables Baseline Trial Trial Trial Trial Trial Trial Trial Trial
w. 8 w. 12 w. 16 6 m 9 m 12 m 18 m 24 m
Biomarkers
HbA1c (mmol/mol) ✓ ✓ ✓ ✓ ✓
Plasmaglucose (fasting) mmol/l ✓ ✓ ✓ ✓ ✓
Triglycerides (mmol/l) ✓ ✓ ✓ ✓ ✓
LDL (mmol/l) ✓ ✓ ✓ ✓ ✓
HDL (mmol/l) ✓ ✓ ✓ ✓ ✓
Total Cholesterol (mmol/l) ✓ ✓ ✓ ✓ ✓
Free fatty acids (mmol/l) ✓ ✓ ✓ ✓ ✓
Insulin (mU/l) ✓ ✓ ✓ ✓ ✓
IGF BP1 (μ/l) ✓ ✓ ✓ ✓ ✓
ApoA1 (g/l) ✓ ✓ ✓ ✓ ✓
ApoB (g/l ✓ ✓ ✓ ✓ ✓
C-peptid (pmol/l) ✓ ✓ ✓ ✓ ✓
Anthropometry
Weight (kg) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
% Body fat ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Height (cm) ✓ ✓
BMI (kg/m2) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Waist circumference (cm) ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Sagittal Abdominal Diameter ✓ ✓ ✓ ✓ ✓ ✓
Resting pulse and blood pressure ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Physical activity
Physical activity level (counts/min) ✓ ✓ ✓ ✓ ✓
Resistance training
Resistance training and hand grip strenght ✓ ✓ ✓ ✓ ✓ ✓ ✓
Questionnaires & Health Measures
Demographic data ✓
Smoking and snuffing habits ✓ ✓
Dietary habits, FFQ ✓ ✓ ✓
Drinking habits ✓ ✓ ✓ ✓
Stress and working conditions ✓ ✓ ✓ ✓ ✓
EQ-5D 3L ✓ ✓ ✓ ✓ ✓
Overall health and sleep ✓ ✓ ✓ ✓ ✓
IPAQ-short ✓ ✓ ✓ ✓ ✓
Social support for exercise ✓ ✓ ✓ ✓ ✓
Self-efficacy for exercise ✓ ✓ ✓ ✓ ✓
Neighborhood environment ✓ ✓ ✓ ✓ ✓
HADS ✓ ✓ ✓ ✓ ✓
PSS ✓ ✓ ✓ ✓ ✓
Swe-PAID-20 ✓ ✓ ✓ ✓ ✓
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to the method of Póvoa et al. [50]. Samples are saved for
later free fatty acid analyses.
Anthropometry
Anthropometric measurements include weight and per-
centage body fat using Tanita digital scale (Model TBF-
300A, Arlington Heights, IL). Weight is measured with
light clothes, no shoes to the nearest 0.1 kg. Height is
measured at the first visit by use of a calibrated stadi-
ometer to the nearest centimeter. Waist circumference
is measured with SECA 201 tape, horizontal around the
waist 2 cm above the umbilicus. Sagittal abdominal
diameter is measured with the subject in a supine pos-
ition with the knees expanded at the level of the umbil-
icus using a Holtain-Kahn abdominal caliper (Holtain,
Ltd., Crosswell, Crymych; Dyfed, UK). Resting pulse and
blood pressure is measured with Omron M6 Comfort.
Objectively measured physical activity
To objectively assess total physical activity as well as sed-
entary time and time spent in different intensities the
ActiGraph GT1M accelerometer (ActiGraph, Pensacola,
FL) will be used. The participants are asked to wear the
accelerometer placed on the back all wakening hours for
seven consecutive days. The accelerations are sampled at
10 Hz i.e. 10 times per second and data is summarized
over one minute and outputted as numerical counts. Total
physical activity is expressed as total counts and steps per
day. Time spent sedentary and in different intensities is
derived from established cut-points according to Freedson
(1998) and Matthews (2005 and 2008) [51–53].
Resistance training
Initiation of regular resistance training is reported contem-
porary with the measurement. Hand grip strength is
measured as a proxy for overall muscle strength [54]. Hand
grip strength is measured in kilograms using the hand-held
Saehan Hydraulic Hand Dynamometer, model SH5001
(former Jamar) (Saehan Corporation, Masan, South Korea).
Questionnaires
A web-site delivered questionnaire is e-mailed to the
participants at baseline, week 12, and at 6, 12 and 24
months. The questionnaire takes 30-40 min to complete,
incorporates several validated questionnaires and some
study specific questions including demographic and life-
style characteristics that aims to evaluate diet, physical
activity, motivational circumstances to be physically ac-
tive, overall health and well-being and problem areas in
diabetes.
Demographic data are collected by study specific ques-
tionnaire with items on civil status, having children
under 18, caring for relatives, educational level and
income.
Smoking and snuffing habits are measured using ques-
tions on current and previous habits and the dose.
An indication of dietary habits is measured by a Food
Frequency Questionnaire (FFQ) developed and validated
by The Swedish National Food Agency. This question-
naire is recommended to use in Swedish populations for
its validity and reproducibility and for comparable rea-
sons [55].
Drinking habits are assessed by two items based on
the amount and regularity of alcohol consumption [56].
Stress and working conditions are measured by 4 items
on over-time, paid overtime, having subordinates and
perceived work security.
Health outcome is measured using The EuroQol
(EQ-5D 3L) that includes questions on mobility, hygiene,
daily activities, pain/ discomfort and anxiety/depression.
Within the particular EQ-5D dimension the responses
are within three levels of severity; no problems, some or
moderate problems and extreme problems. The question-
naire also measures overall health status on a vertical vis-
ual analogue scale where 0 indicates worst imaginable
health and 100 best imaginable health [57]. An approval to
use the instrument in the current project is received from
The EuroQol group.
Overall health and sleep is measured by a 1-100 scale
for health condition where 0 is worst possible and 100 is
best possible. One question on difficulties falling asleep
and one question on sleep quality.
Subjectively assessed physical activity is measured with
The International Physical Activity Questionnaire (IPAQ),
a self-administered 7-item questionnaire that evaluates the
frequency and duration of walking, moderate- and
vigorous-intensity physical intensity, and minutes spent
sitting during the past week [58].
Social support for exercise is measured with Physical
Activity Social Support (PASS) first developed by Sallis
et al. [59]. The PASS examines general support (1 item),
friend (2 items), family (2 items) and colleagues support
for exercise. PASS is using a 4-point Likert response
scale (1 = strongly agree to 4 = strongly disagree).
Self-efficacy for exercise is measured with the 5-item
scale The Self-Efficacy for Exercise Scale. It assess one’s
confidence to continue exercising when feeling tired, be-
ing in a bad mood, not having time, being on vacation
and at bad weather [60].
Neighborhood environment is assessed by the scale
Neighborhood Environment developed by Mujahid
et al., 2007 and using a 5-point responses (1 = strongly
agree to 5 = strongly disagree) [61]. In this study 17
items about abilities to undertake exercise and walk-
ing, availability of foods, safety and social environment
are used.
Depression and anxiety is measured with The Hospital
Anxiety and Depression Scale (HADS): HADS is a 14
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item questionnaire consisting of two subscales; depres-
sion and anxiety, with seven items each. The items are
graded on a four-point Likert scale ranging from 0-3.
The total score ranges from 0-21 for the HADS depres-
sion scale and ranges from 0-21 for the HADS anxiety
scale [62].
Stress is measured with The Perceived Stress Scale
(PSS) which is a 14- item questionnaire used to measure
how stressful different situations in one's life are per-
ceived (Cohen et al. 1983). The items are graded on a
five-point Likert scale. The total score for PSS ranges
from 0-56. Eskin et al., 1996 have psychometrically
tested the Swedish version of PSS [63].
Diabetes distress is measured using The Problem
Areas in Diabetes questionnaire (Swe-PAID-20): This is
a 20 items questionnaire translated in to Swedish by
Amsberg et al. [64]. The patient rates their distress with
having diabetes on a five-point Lickert scale, from 0 =
not a problem to 4 = serious problem. The total score
ranges from 0-100. The original version of PAID was
developed by Polonsky et al., 1995 [65]. These questions
are only answered by the participants diagnosed with
diabetes.
Fidelity criteria
Attendance and notes on reasons for absence at individual
visits and group consultation is made after each session.
Compliance to registration of steps is made monthly and
reasons for failing to register steps is tracked and noted.
Notes from the MI talk are registered in the health jour-
nal. The project group has regular meetings to discuss
issues regarding MI talks, physical activity on prescription
and measurements, in order to assure the routines of both
measurements and intervention components. The quality
of each individual counseling session is assessed on a 1-10
scale by the diabetes specialist nurse for both motivational
interviewing and physical prescription. A qualitative study
to explore how the participants perceived the support as
well as barriers and facilitators will help to evaluate the
intervention efficacy from a patient perspective.
Sample size and planned statistical analysis
The sample size calculation assumed 80 % power and
was calculated drawing on previous literature [14, 66] by
statistical power analysis. To detect a difference of > 0.6
mmol/mol in HbA1c with a standard deviation of
1.2 % at 12 months between group A and B and between
group A and C we need 56 per group. Taking account
the compliance and drop-out (30 %) and patients which
decline participation (20 %) we need in group A 100
patients, in group B 100 patients and in group C 110
patients.
The study will be evaluated with both quantitative and
qualitative methods and a cost-effectiveness analysis will
be performed. The CONSORT 2010 statement will be
used for description and analysis [45]. Data will be ana-
lyzed following the Intent-to-treat approach (ITT). De-
scriptive statistics will be used to describe the study
population at baseline. The study data will be examined
for outliers, normality and missing data. Potential con-
founders as (e.g. BMI at baseline, gender and age) will
be used if there are differences at baseline.
Un-paired and paired tests, correlation coefficients as
well as ANOVAs will be used to assess the bivariate ef-
fects of the interventions and to analyze within-group
and between-group differences and changes. In addition,
logistic regression models and/or cluster analyses will be
performed to analyze issues related to dose–response
and responder characteristics. SPSS 22 (SPSS Inc.,
Chicago, IL, USA) will be used for the statistical analysis.
Limitations
Individuals with pre-diabetes and diabetes are random-
ized in the same group and it can be discussed whether
the same decline in HbA1c can be expected in individ-
uals with pre-diabetes. Furthermore the participants in
the control group may be influenced by participating in
a research study and being assessed regularly. As they
agree to join they are highly motivated to change their
physical activity level and we expect many of them to
succeed in this by their own. This could make compari-
son of between-group differences problematic. More-
over, the control group is assessed by the same staff as
group A and B, for practical and financial reasons. This
staff is trained in motivational interviewing and it might
be difficult to treat the patients differently. At measure-
ments participants from group A, B and C are given
different schedules, group A participants are offered
more time and a systematic motivational interviewing
following a set of questions.
Discussion
With an ageing population and increasing incidence of
pre-diabetes and diabetes, it is of high importance to con-
struct, implement and evaluate cost-effective preventive
methods adjusted for the health care system [41]. It is
well-documented that walking, exercise groups and advice
on prescription are effective at a low cost per participant
over 12 months [34]. It is known that more support gives
more long-term effect, although it is also evident that ra-
ther simple interventions can provide a worthwhile effect
[67]. This study aims at bringing more knowledge to what
intensity such methods need to be at, to be as cost-
effective as possible. Long-term interventions are rare in
diabetes intervention research [41]. This study will show if
support for two year’s maintenance is effective. A further
strength is that it brings theory into practice and adds evi-
dence for methods by which behavior change techniques
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may be delivered and embedded in the day to day care in
a time-effective way [43, 68]. The methods used and evalu-
ated in Sophia Step Study may be easily implemented in
the primary health care setting with little new competence
and administrative time needed. The study aims to raise
the patient’s awareness and self-management and assess
the impact of self-perceived general health, as proposed by
the US National Standards for Diabetes Self-Management
Education and Support [69], WHO Europe’s policy frame-
work Health 2020 [26] and value-based care [70] which is
being implemented in Sweden.
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